Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis

Citation
T. Kumada et al., Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis, J HEPATOL, 30(1), 1999, pp. 125-130
Citations number
42
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
JOURNAL OF HEPATOLOGY
ISSN journal
01688278 → ACNP
Volume
30
Issue
1
Year of publication
1999
Pages
125 - 130
Database
ISI
SICI code
0168-8278(199901)30:1<125:CUOLCA>2.0.ZU;2-R
Abstract
Background/Aims: Blood concentration levels of alpha-fetoprotein like the L ens culinaris agglutinin-reactive fraction (AFP-L3) are a useful marker for predicting the long-term prognosis of hepatocellular carcinoma. This study investigated the relationship between serum AFP-L3 and various imaging mod alities. Methods: Sixty-three patients with small hepatocellular carcinomas less tha n or equal to 2 cm in diameter were studied. Serum AFP-L3 concentrations we re measured by lectin-affinity electrophoresis coupled with antibody-affini ty blotting and expressed as % AFP-L3 (the percent of AFP-L3 as total AFP). A clinical "cutoff level" of 10% was used in this study to indicate the pr esence of hepatocellular carcinoma. Selective hepatic intraarterial digital subtraction angiography (DSA), ultrasonographic angiography with carbon di oxide microbubbles (USAG), and computed tomography during arterial portogra phy (CTAP) were performed to evaluate the hemodynamics of hepatic nodules. Results: fourteen (22.2%) of the 63 patients were positive for % AFP-L3. Th e % AFP-L3 levels (n=45, 4.4%) of patients with hypervascular tumors were s ignificantly higher than those (n=15, 0.0%) of patients with isovascular or hypovascular tumors as determined by USAG (p=0.0061). The % AFP-L3 levels (n=53, 4.4%) of patients with a negative portal blood supply were significa ntly higher than the % AFP-L3 levels (n=7, 0.0%) of patients with a positiv e portal blood supply as determined by CTAP (p=0.0140). The % AFP-L3 levels of patients with tumors with a long doubling time (DT) were significantly lower than for patients with tumors with a short DT (p=0.0176). Conclusion: AFP-L3 is a positive indicator which may be more specific for s mall advanced hepatocellular carcinoma.